Physician
General Surgery
Dr. Seza A. Gulec, MD
|
|
Give Review
Seza Gulec is an expert in the field of General Surgery. He received awards:"Fellow (FACS)". Seza Gulec is a published doctor. He has 52 publications published. The most current publication "Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma." Seza A. Gulec accepts all Medicare patients.
Publications
- I-124 PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CANCER: CLINICAL AND QUANTITATIVE IMAGE ANALYSIS.
- Yttrium-90 Microsphere-selective Internal Radiation Therapy With Chemotherapy (Chemo-SIRT) for Colorectal Cancer Liver Metastases: An In Vivo Double-Arm-Controlled Pha...
- Lyophilized Kit for the Preparation of the PET Perfusion Agent [(68)Ga]-MAA.
- (68)Ga-NOTA-CHSg and (99m)Tc-CHSg Labeled Microspheres for Lung Perfusion and Liver Radiomicrospheres Therapy Planning.
- Elevated levels of C-reactive protein are associated with impaired coronary collateral development.
- A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging.
- Peripheral facial nerve palsy after high-dose radioiodine therapy in patients with papillary thyroid carcinoma.
- Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.
- Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2.
- Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
- Post-surgical ablation of thyroid remnants with high-dose (131)I in patients with differentiated thyroid carcinoma.
- Unfiltered sulfur colloid and sentinel node biopsy for breast cancer: technical and kinetic considerations.
- Fable on the superior laryngeal nerve.
- Somatostatin receptor expression in Hürthle cell cancer of the thyroid.
- Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.
- Gamma probe guided sentinel node biopsy in breast cancer.
- Antiangiogenic therapy with somatostatin receptor-mediated in situ radiation.
- Clinical utility of frozen section in sentinel node biopsy in breast cancer.
- Sentinel lymph node localization in early breast cancer.
- A 3-d liver segmentation method with parallel computing for selective internal radiation therapy.
- Treatment of advanced pancreatic carcinoma with 90Y-clivatuzumab tetraxetan: A Phase I single-dose escalation trial.
- The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radia...
- Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
- Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.
- 2009 EANM parathyroid guidelines.
- Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease.
- Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
- Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safet...
- Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres.
- PET probe-guided surgery.
- Radio-guided surgery in neuroendocrine tumors.
- A tribute to a nuclear surgeon.
- Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
- Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease.
- PET probe-guided surgery: applications and clinical protocol.
- A multimodality localization technique for radio-guided surgery.
- Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor t...
- A surgical perspective on positron emission tomography.
- Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations.
- Case 3. Positron emission tomography-computed tomography diagnosis of metastatic melanoma with intussusception.
- Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.
- Gamma-guided diagnostic peritoneal lavage for detection of bowel perforation.
- Breast carcinoma originating in a fibroadenoma.
- A new in vitro assay for human tumor angiogenesis: three-dimensional human tumor angiogenesis assay.
- The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.
- Preoperative localization and radioguided parathyroid surgery.
- Optimization of the gamma probe-guided parathyroidectomy.
- Hepatectomy in children under total hepatic occlusion.
- Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
- Gamma probe-guided lymph node dissection ('gamma picking') in differentiated thyroid carcinoma.
- Cytoreductive surgery in patients with advanced-stage carcinoid tumors.
Schools
Ankara Universitesi Tip Fakultesi
Doctors Specialties
- General Surgery
- Nuclear Medicine
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Louisiana State University -
Memorial Sloan-Kettering Cancer Center -
Maimonides Medical Center -
Ankara University Faculty of Medicine
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1780664227 | |
| NPPES Provider LastName | GULEC | |
| NPPES Provider FirstName | SEZA | |
| NPPES Provider ZIPCode | 331383163 | |
| NPPES Provider State | FL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 108.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 40.0 | |
| Percent Opioid Claims | 37.04 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780664227 |
| Last Name Of The Provider | GULEC |
| First Name Of The Provider | SEZA |
| View All |
Similar Doctors
|
Dr. Elias Chousleb Mizrahi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Taylor Jr., MD |
|
Dr. Gary L. Glick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Humberto Basto, MD |
|
|
Dr. John A. King, MD |
|
|
Dr. Chacko I. Nebu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Natan Z. Majerowick |